Short Term Response of Breast Milk Micronutrient Concentrations to a Lipid Based Nutrient Supplement in Guatemalan Women
2 other identifiers
interventional
30
1 country
1
Brief Summary
Research goals include evaluating the relative impact of maternal nutritional status versus recent dietary intake on breast milk micronutrient composition, and evaluating the impact of a maternal lipid based nutrient supplement (LNS) on breast milk micronutrient composition.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2015
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 22, 2015
CompletedStudy Start
First participant enrolled
May 1, 2015
CompletedFirst Posted
Study publicly available on registry
June 8, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2015
CompletedSeptember 9, 2015
September 1, 2015
3 months
April 22, 2015
September 4, 2015
Conditions
Outcome Measures
Primary Outcomes (5)
Change in Cobalamin (vitamin B12) in Breast Milk
We are observing the change in breast milk vitamin B12 over the course of 8 hours.
Breast milk cobalamin will be assessed in an 8-hour milk sample on each of three study visit days (Visits 2, 3, and 4.) Study visits/weeks 2, 3, & 4 will each be held approximately 1 week apart.
Change in Pyridoxal (vitamin B6) in Breast Milk
We are observing the change in breast milk vitamin B6 over the course of 8 hours.
Breast milk pyridoxal will be assessed in an 8-hour milk sample on each of three study visit days (Visits 2, 3, and 4.) Study visits/weeks 2, 3, & 4 will each be held approximately 1 week apart.
Change in Riboflavin (vitamin B2) in Breast Milk
We are observing the change in breast milk vitamin B2 over the course of 8 hours.
Breast milk riboflavin will be assessed in an 8-hour milk sample on each of three study visit days (Visits 2, 3, and 4.) Study visits 2, 3, & 4 will each be held approximately 1 week apart.
Change in Niacin (vitamin B3) in Breast Milk
We are observing the change in breast milk vitamin B5 over the course of 8 hours.
Breast milk niacin will be assessed in an 8-hour milk sample on each of three study visit days (Visits 2, 3, and 4.) Study visits 2, 3, & 4 will each be held approximately 1 week apart.
Change in Thiamin (vitamin B1) in Breast Milk
We are observing the change in breast milk vitamin B1 over the course of 8 hours.
Breast milk thiamin will be assessed in an 8-hour milk sample on each of three study visit days (Visits/weeks 2, 3, and 4.) Study visits 2, 3, & 4 will each be held approximately 1 week apart.
Secondary Outcomes (6)
Maternal cobalamin (vitamin B12) status
Measured once prior to first study visit (week 1)
Maternal pyridoxal (vitamin B6) status
Measured once prior to first study visit (week 1)
Maternal riboflavin (vitamin B2) status
Measured once prior to first study visit (week 1)
Maternal niacin (vitamin B3) status
Measured once prior to first study visit (week 1)
Maternal thiamin (vitamin B1) status
Measured once prior to first study visit (week 1)
- +1 more secondary outcomes
Study Arms (6)
Group 1
EXPERIMENTALTreatment 1: Control - no supplement given Treatment 2: Bolus - LNS supplement provided in one dose Treatment 3: Divided Dose - LNS supplement provided in 3 doses
Group 2
EXPERIMENTALTreatment 1: Control - no supplement given Treatment 3: Divided Dose - LNS supplement provided in 3 doses Treatment 2: Bolus - LNS supplement provided in one dose
Group 3
EXPERIMENTALTreatment 2: Bolus - LNS supplement provided in one dose Treatment 1: Control - no supplement given Treatment 3: Divided Dose - LNS supplement provided in 3 doses
Group 4
EXPERIMENTALTreatment 2: Bolus - LNS supplement provided in one dose Treatment 3: Divided Dose - LNS supplement provided in 3 doses Treatment 1: Control - no supplement given
Group 5
EXPERIMENTALTreatment 3: Divided Dose - LNS supplement provided in 3 doses Treatment 2: Bolus - LNS supplement provided in one dose Treatment 1: Control - no supplement given
Group 6
EXPERIMENTALTreatment 3: Divided Dose - LNS supplement provided in 3 doses Treatment 1: Control - no supplement given Treatment 2: Bolus - LNS supplement provided in one dose
Interventions
One LNS supplement provided in a single bolus dose in the morning
One LNS supplement provided in 3 separate portions throughout the study visit
Eligibility Criteria
You may qualify if:
- Mother 18-40 years of age
- Apparently healthy, with no acute illness
- Willing to stay in clinic for breast milk sampling, and adhere to all study procedures
- months of lactation and ≥ 8 breast feeding episodes per day (usual frequency is \>20 times/day)
- Last birth was a singleton birth
- Only breastfeeding one child
- Child is 4-6 months of age
You may not qualify if:
- Current supplement use (iron + folic acid excepted)
- Self reported mastitis or other breast infections
- Reported problems with breastfeeding which might affect study procedures
- Last birth was premature (\>4 weeks pre-term by maternal report)
- Measured body mass index (BMI) of less than 18.5 or a measured mid upper arm circumference (MUAC) of less than 12.5 cm
- Temporary- if the mother or her infant present with an acute illness, (for example flu or diarrhea,) they will be rescheduled to return on a later date when both are apparently healthy.
- Allergy to milk, milk products, or peanuts.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- USDA, Western Human Nutrition Research Centerlead
- University of California, Daviscollaborator
- Blum Center for Developing Economiescollaborator
- Fogarty International Center of the National Institute of Healthcollaborator
- Center for the Studies of Sensory Impairment, Aging and Metabolism (CeSSIAM)collaborator
Study Sites (1)
USDA, ARS, Western Human Nutrition Research Center
Davis, California, 95616, United States
Related Publications (1)
Donohue JA, Solomons NW, Hampel D, Shahab-Ferdows S, Orozco MN, Allen LH. Micronutrient supplementation of lactating Guatemalan women acutely increases infants' intake of riboflavin, thiamin, pyridoxal, and cobalamin, but not niacin, in a randomized crossover trial. Am J Clin Nutr. 2020 Sep 1;112(3):669-682. doi: 10.1093/ajcn/nqaa147.
PMID: 32649760DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Juliana A Haber, B.S.
USDA WHNRC, UC Davis
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 22, 2015
First Posted
June 8, 2015
Study Start
May 1, 2015
Primary Completion
August 1, 2015
Study Completion
August 1, 2015
Last Updated
September 9, 2015
Record last verified: 2015-09